IBB 146.40 iShares Biotechnology ETF
| Range: | 111.83-150.57 | Vol Avg: | 1159495 | Last Div: | 0.45 | Changes: | 2.44 |
| Beta: | 0.82 | Cap: | 10.15B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Financial Services | IPO: | Mon Feb 12 2001 | Empoloyees: | |||
| CUSIP: | 464287556 | CIK: | 0001100663 | ISIN: | US4642875565 | Country: | US |
The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Stock Details
Neutral 0.09
IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral
I reiterate a hold rating on IBB due to its stretched valuation at nearly 20x earnings and...
seekingalpha.com·Mon Oct 14 2024
Positive 0.30
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Making its debut on 02/05/2001, smart beta exchange traded fund iShares Biotechnology ETF ...
zacks.com·Wed Oct 09 2024
Positive 0.32
Should You Invest in the iShares Biotechnology ETF (IBB)?
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity m...
zacks.com·Tue Oct 01 2024
Positive 0.13
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
As a new regime and phase begin for the market and economy, after the FED cut interest rat...
marketbeat.com·Mon Sep 23 2024
Positive 0.24
Biotech Breakout: Stocks for Your Watchlist
After a prolonged consolidation and downtrend following the pandemic-driven surge, the bio...
marketbeat.com·Thu Sep 12 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow